Filibusters & Fine Print Podcast Por AMGA (American Medical Group Association) arte de portada

Filibusters & Fine Print

Filibusters & Fine Print

De: AMGA (American Medical Group Association)
Escúchala gratis

OFERTA POR TIEMPO LIMITADO. Obtén 3 meses por US$0.99 al mes. Obtén esta oferta.

Looking for insights and analysis of the policies shaping American healthcare, mixed in with (mostly) friendly banter and occasional culture commentary? Scroll no more, you’ve found Filibusters and Fine Print. Hosted by AMGA’s seasoned public policy team with too many years of Capitol Hill and executive branch experience to count, this podcast unpacks the latest legislative and regulatory developments affecting healthcare providers.

From Medicare payment reforms to the fine print of federal regulations, we break down complex policy issues, offering expert insights, candid conversations, and the inside scoop on what’s happening in Washington. Whether you're a healthcare leader, policymaker, or just someone who wants to stay informed, tune in to navigate the ever-evolving landscape of healthcare policy with us. Plus, you might walk away with a fashion tip or restaurant recommendation!

AMGA 2025
Ciencia Política Política y Gobierno
Episodios
  • Season 2, Ep #5 – Chit Chat for Change
    Sep 30 2025

    In Season #2, Episode #5: The AMGA team discusses the importance of developing relations with congressional staff and providing real-world experience and expertise. The team explains how offering concrete policy recommendations will go a long way to achieving policy aims. Additional details and all episodes are available on the AMGA website.

    Más Menos
    24 m
  • Season 2, Ep #4 – Congress Has Purse.
    Sep 23 2025

    With another government shutdown looming, the AMGA team explains how the appropriation process is supposed to work, in the context of a viral TikTok trend.

    Más Menos
    22 m
  • Season 2, Ep #3 – A Circuit City Model for 340B Drugs?
    Sep 16 2025

    HRSA’s new 340B model will test a rebate model for 340B drugs, requiring providers to file for a rebate rather than receiving an upfront discount. The AMGA discusses the ramifications of this change, along with CMS’ plan to accelerate a repayment plan as part of its proposed outpatient rule.

    Más Menos
    21 m
Todavía no hay opiniones